Authors:
Rapakko, K
Allinen, M
Syrjakoski, K
Vahteristo, P
Huusko, P
Vahakangas, K
Eerola, H
Kainu, T
Kallioniemi, OP
Nevanlinna, H
Winqvist, R
Citation: K. Rapakko et al., Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites, BR J CANC, 84(1), 2001, pp. 116-119
Authors:
Hakkola, J
Raunio, H
Purkunen, R
Saarikoski, S
Vahakangas, K
Pelkonen, O
Edwards, RJ
Boobis, AR
Pasanen, M
Citation: J. Hakkola et al., Cytochrome P450 3A expression in the human fetal liver: Evidence that CYP3A5 is expressed in only a limited number of fetal livers, BIOL NEONAT, 80(3), 2001, pp. 193-201
Citation: Ti. Ala-kokko et al., Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacology, INT J OB AN, 9(1), 2000, pp. 26-38
Authors:
Zheng, A
Mantymaa, P
Saily, M
Savolainen, ER
Vahakangas, K
Koistinen, P
Citation: A. Zheng et al., p53 pathway in apoptosis induced by all-trans-retinoic acid in acute myeloblastic leukaemia cells, ACT HAEMAT, 103(3), 2000, pp. 135-143
Authors:
Olivero, OA
Parikka, R
Poirier, MC
Vahakangas, K
Citation: Oa. Olivero et al., 3 '-azido-3 '-deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT, MUT RES-F M, 428(1-2), 1999, pp. 41-47
Authors:
Huusko, P
Castren, K
Launonen, V
Soini, Y
Paakkonen, K
Leisti, J
Vahakangas, K
Winqvist, R
Citation: P. Huusko et al., Germ-line TP53 mutations in Finnish cancer families exhibiting features ofthe Li-Fraumeni syndrome and negative for BRCA1 and BRCA2, CANC GENET, 112(1), 1999, pp. 9-14
Authors:
Serpi, R
Piispala, J
Jarvilehto, M
Vahakangas, K
Citation: R. Serpi et al., Thapsigargin has similar effect on p53 protein response to benzo[a]pyrene-DNA adducts as TPA in mouse skin, CARCINOGENE, 20(9), 1999, pp. 1755-1760